TY - JOUR
T1 - GnRH agonist versus GnRH antagonist in ovarian stimulation
T2 - the influence of body mass index on in vitro fertilization outcome
AU - Rabinson, Jacob
AU - Meltcer, Simion
AU - Zohav, Efraim
AU - Gemer, Ofer
AU - Anteby, Eyal Y.
AU - Orvieto, Raoul
PY - 2008/2/1
Y1 - 2008/2/1
N2 - In an attempt to examine whether body mass index (BMI) may influence IVF outcome in patients undergoing COH with either GnRH-agonist (agonist group) or GnRH-antagonist (antagonist group), we studied 799 IVF cycles: 481 in the agonist group and 318 in the antagonist group. In patients with BMI >25 kg/m2, COH with either GnRH-agonist or GnRH-antagonist achieved a comparable outcome; whereas in patients with BMI <25 kg/m2, the use of GnRH-agonist suppressive protocol revealed significantly higher pregnancy rates.
AB - In an attempt to examine whether body mass index (BMI) may influence IVF outcome in patients undergoing COH with either GnRH-agonist (agonist group) or GnRH-antagonist (antagonist group), we studied 799 IVF cycles: 481 in the agonist group and 318 in the antagonist group. In patients with BMI >25 kg/m2, COH with either GnRH-agonist or GnRH-antagonist achieved a comparable outcome; whereas in patients with BMI <25 kg/m2, the use of GnRH-agonist suppressive protocol revealed significantly higher pregnancy rates.
UR - http://www.scopus.com/inward/record.url?scp=38949104426&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2007.03.007
DO - 10.1016/j.fertnstert.2007.03.007
M3 - Article
C2 - 17582402
AN - SCOPUS:38949104426
SN - 0015-0282
VL - 89
SP - 472
EP - 474
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 2
ER -